JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH

Online ISSN: 2029-283X

www: http://www.ejomr.org
Journal DOI: 10.5037/jomr.2029.283X

AUTHOR GUIDELINES
Relevant documents:MANDATORY SUBMISSION FORM, ORIGINAL ARTICLE TEMPLATE
CONTENT OF AUTHOR GUIDELINES:
1. GENERAL
2. ETHICAL GUIDELINES
3. SUBMISSION OF ARTICLES
4. ARTICLE TYPES ACCEPTED
5. ARTICLE PREPARATION

1. GENERAL
JOMR conveys scientific progress in the field of oral and maxillofacial medicine and its related
areas to clinicians, teachers and researchers concerned with the application of this information for
the benefit of patients. JOMR publishes original scientific articles, literature reviews, and clinical
case reports, proceedings of pertinent symposia or conferences and information for dentists, oral
pathologists and maxillofacial surgeons, other specialists of medicine and public health. Original
articles are considered for publication on the condition they have not been published or submitted
for publication elsewhere.

2. ETHICAL GUIDELINES
JOMR adheres to the below ethical guidelines for publication and research.
2.1. AUTHORSHIP
Authors submitting a paper do so on the understanding that the article have been read and approved
by all authors and that all authors agree to the submission of the article to the Journal. All named
authors must have made an active contribution to the conception and design and/or analysis and
interpretation of the data and/or the drafting of the paper and all must have critically reviewed its
content and have approved the final version submitted for publication. Participation solely in the
acquisition of funding or the collection of data does not justify authorship.
JOMR adheres to the definition of authorship set up by The International Committee of Medical
Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1)
substantial contributions to conception and design of, or acquisition of data or analysis and
interpretation of data, 2) drafting the article or revising it critically for important intellectual content
and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.
2.2. ETHICAL APPROVALS
a) Experimentation involving human subjects
Experimentation involving human subjects will only be published if such research has been
conducted in full accordance with ethical principles, including the World Medical Association
Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/) and the additional
requirements, if any, of the country where the research has been carried out. Articles must be
1

accompanied by a statement that the experiments were undertaken with the understanding and
written consent of each subject and according to the above mentioned principles. A statement
regarding the fact that the study has been independently reviewed and approved by an ethical board
should also be included. Editor reserve the right to reject papers if there are doubts as to whether
appropriate procedures have been used.
Example: "All participants have read and signed informed consent form. The use of human subjects
in this study has been reviewed and approved by the Health Science Institutional Review Board
(IRB) of the University of New York".
b) Experimentation involving animals
When experimental animals are used the methods section must clearly indicate that adequate
measures were taken to minimize pain or discomfort. Experiments should be carried out in
accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA
regarding the care and use of animals for experimental procedures or with the European
Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local
laws and regulations.
Example: "The experimental protocol was approved by the Animals Experiments Committee of the
Catholic University of Leuven".
2.3. CLINICAL TRIALS
Clinical trials should be reported using the CONSORT guidelines available at www.consortstatement.org. A CONSORT checklist should also be included in the submission material.
JOMR encourages authors submitting articles reporting from a clinical trial to register the trials in
any of the following free, public clinical trials registries:
www.clinicaltrials.gov,
http://clinicaltrials.ifpma.org/no_cache/en/myportal/index.htm,
http://isrctn.org/. The clinical trial registration number and name of the trial register will then be
published with the paper.
2.4. ACKNOWLEDGMENTS AND DISCLOSURE STATEMENTS
a) Acknowledgments
At the end of the Discussion, acknowledgments may be made to individuals who contributed to the
research or the article preparation at a level that did not qualify for authorship. This may include
technical help or participation in a clinical study. Authors are responsible for obtaining written
permission from persons listed by name.
b) Disclosure statement
Possible conflict(s) of interests should be revealed. Authors are required to disclose all sources of
institutional, private and corporate financial support for their study. Suppliers of materials (for free
or at a discount from current rates) should be named in the source of funding and their location
(town, state/county, country) included. Other suppliers will be identified in the text. If no funding
has been available other than that of the author's institution, this should be specified upon
submission. Authors are also required to disclose any potential conflict of interest. These include
financial interests (for example patent, ownership, stock ownership, consultancies, speaker's fee,) or
provision of study materials by their manufacturer for free or at a discount from current rates.
Author's conflict of interest (or information specifying the absence of conflicts of interest) and the
sources of funding for the research will be published under a separate heading entitled:
"ACKNOWLEDGMENTS AND DISCLOSURE STATEMENTS".
Examples:
1. Acknowledgments to individuals who contributed to the research or the article preparation: "The
authors wish to thank Prof. Dr. P. Peterson for his assistance in digitizing radiographs and analyzing
marginal bone-level changes and Prof. Dr. G. Wakens for his contribution in recruiting and
referring patients".
2

2. If there are no conflicts of interests: "The authors report no conflicts of interest related to this
study", or "No external funding, apart from the support of the authors' institution, was available for
this study".
3. If there was institutional, private and corporate financial support for the study: "Supported by
NH-NIDCR grants DE 13076, DE14269, and the ITI Foundation for the Promotion of Oral
Implantology, Basel Switzerland (Grant Number 284/2003)".
2.5. APPEAL OF DECISION
The decision on a paper is final and cannot be appealed.
2.6. PERMISSIONS AND WAIVERS
a) Permissions
Permission of author and publisher must be obtained for the direct use of material (text, photos, and
drawings) under copyright that does not belong to the author.
b) Waivers
Waivers must be obtained for photographs showing persons. When such waivers are not supplied,
faces will be masked to prevent identification.
Permissions and waivers should be emailed along with the Mandatory Submission Form to the
Editorial Assistant.
2.7. MANDATORY SUBMISSION FORM
(download MANDATORY SUBMISSION FORM)
Authors submitting a paper do so on the understanding that the work and its essential substance
have not been published before and is not being considered for publication elsewhere. The
submission of the article by the authors means that the authors automatically agree to assign
copyright to JOMR if and when the article is accepted for publication. The articles published in this
journal are protected by copyright, which covers translation rights and the exclusive right to
reproduce and distribute all of the articles printed in the journal.
The Mandatory Submission Form, which can be found on the website, should be signed by all
authors, scanned and emailed to Editorial Assistant info@ejomr.org.
Multiple forms are acceptable. Assignment of the copyright is a condition of article publication.

3. SUBMISSION OF ARTICLES
3.1. ARTICLE SUBMISSION ONLINE
Articles should be uploaded as Microsoft PC-Word file with tables and figures included at the end
of the document. The filename must be typed exactly as "text.doc". Before attempting to insert a
figure or illustration, its file size should be checked and reduced if necessary. Inserting an overly
large figure file can cause the file upload procedure to fail. For review purposes, a figure file does
not need to be larger than 500 Kbytes. We suggest that you attempt to keep the total file size of your
word document below 4 Mbytes. This may require you to reduce the file size of your figures using
an image application. Maximum file size is 15 Mbytes. No paper version is required. High quality
images must be presented in separate files assigning filenames formed including figures numbers
(e.g., Figure 1.jpg, Figure 2.tif, Figure 3.png, Figure 4.psd). even if the figures are included in your
article file.
Original articles are considered for publication on the condition that they have not been published
or submitted for publication elsewhere.
The publisher reserves the right to edit articles to fit the space available and to ensure conciseness,
clarity, and stylistic consistency, subject to the author's final approval.
Articles are reviewed and selected in a blinded process by editors and appropriate content experts.
Therefore, it is important that submitted articles and illustrations do not contain information that
3

will identify the origin of the paper (except for the title page, which will not be sent to the
reviewers).
Important: In order to facilitate review process author should suggest the names and current email
addresses of one or few potential international reviewers whom author considers to be capable of
reviewing article. In addition to authors choice the journal editor will choose one or two reviewers
as well.
After submission author will receive an e-mail to confirm receipt of article. If author do not receive
the confirmation email after 24 hours he should check his e-mail address carefully in the system and
contact JOMR Assistant Editor (info@ejomr.org).
3.2. INTERNET-BASED PEER REVIEW PROCESS
Once new article are received, Editorial office will create PDF file version of new article. Also, the
article/correspondent details are entered into the system database, by the editorial assistant.
The Editor-in-Chief and/or Associate Editors will then select a number (at least 2) of reviewers who
are authorities in the field and who are deemed to have the relevant experience and expertise to
provide a full and cogent review of the article. A copy of the title and abstract is made available to
them to assist them in deciding whether they have the pertinent experience to review the article. If
they accept the assignment to review, they will receive original article and further details. After that
they must Log-In to the database, where they will submit to their comments.
Reviewers are allocated 6 weeks for evaluation of submitted article. An automatic e-mail Letter of
Reminder is sent after 5 weeks by the system database if the review has not been returned.
When the reviews are returned to the editorial office they are forwarded to an Associate Editor, who
will then make a recommendation.
The Editor-in-Chief will then make a final decision based on this recommendation. The
corresponding author is contacted via e-mail with the decision and reviewers' reports. The reviewers
are informed of the decision and are sent a copy of the other reviewers' reports for their information.
Revised articles follow a similar procedure. Upon resubmission, the Editor-in-Chief or Associate
Editor evaluates the revision and decides whether it can be accepted or whether it is to be sent to the
same external reviewers who undertook the initial evaluation. Reviewers are allocated a maximum
of 2 weeks for the 2nd review of resubmitted articles.
Important: All corrections in resubmitted articles (Microsoft PC-Word file) should be done in
blue color, in order that reviewers and editor could focus only on those areas where author have
made the changes.

4. ARTICLE TYPES ACCEPTED

4.1. ORIGINAL ARTICLES
Original evidence-based research articles of high scientific merit in the field of clinical oral and
maxillofacial rehabilitation and physiology. Also original research articles related with basic aspects
of oral and maxillofacial rehabilitation, e.g. in vitro and laboratory studies.
Original Research Articles must describe novel and significant observations and provide sufficient
detail so that the findings can be critically evaluated and, if necessary, repeated.
4.2. LITERATURE REVIEWS
These are focused reviews of basic and clinical science related to oral and maxillofacial pathology.
These reviews should be concise and address an important and timely clinical question. The review
should be based on a critical assessment of the literature, and may include data or examples from
the research or clinical experience of the author(s). Authors should discuss clinical relevance and
future projections. Reviews should take a broad view of the field rather than merely summarizing
the authors own previous work, so extensive citation of the authors own publications is
discouraged. At-large submissions will be considered, but authors should contact the Editor-inChief before developing an article to avoid duplicating a topic already in preparation. Papers should
4

be balanced, literature-based reviews. Articles should be written at a level instructive to Journal

readers. For example, clear denitions of abbreviations and a glossary of terms may be useful for
defining highly technical or new terminology. Since critical reviews require selection of reports and
interpretation of data, authors should not have a financial interest in the companies making products
or providing services described in the review.

4.3. CASE REPORTS

These papers report a sufficient number of consecutive or randomized cases to make a persuasive
argument for or against the procedure, technique, or concept under discussion. Cases should be
relatively homogeneous so that a systematic evaluation of one type of disease, lesion, or condition
is made for the procedure under consideration. Also, treatment and documentation should be
consistent and standardized for all cases. It is recognized that definitive evidence for the safety and
efficacy of any procedure, drug, or device comes primarily from well-designed, randomized,
controlled trials. However, well-executed case series may lead to hypotheses about the usefulness of
new and innovative procedures, drugs, or devices and may therefore be of value to the progress of
clinical science. They may be followed by commentaries, or a review on state of art of the clinical
problem addressed in the case report. Concise literature relevant to the case should be included.
Figures, where necessary, should be targeted to illustrate the text, but should be limited in number.

5. ARTICLE PREPARATION
5.1. FORMAT
The journal will follow as much as possible the recommendations of the International Committee of
Medical Journal Editors (Vancouver Group) in regard to preparation of articles and authorship
(Uniform requirements for articles submitted to biomedical journals. Ann Intern Med 1997;126:3647). See www.icmje.org.
a) Language
The language of publication is British English. Authors for whom English is a second language
might choose to have their article professionally edited by an English speaking person before
submission to make sure the English is of high quality. Articles which are not written in fluent
English will be rejected automatically without refereeing.
b) Abbreviations, Symbols and Nomenclature
The symbol % is to be used for percent, h for hour, and min for minute and s for second. In vitro, in
vivo, in situ and other Latin expressions are to be italicized. Use only standard abbreviations. All
units will be metric. Use no roman numerals in the text. In decimals, a decimal point and not a
comma will be used. Avoid abbreviations in the title. The full term for which an abbreviation stands
should precede its first use in the text unless it is a standard unit of measurement. In cases of doubt,
the spelling orthodoxy of Webster's new international dictionary will be adhered to. Individual teeth
should be identified full name or using the FDI two-digit system.
c) Scientific Names
Proper names of bacteria should be binomial and should be italicized. The full proper name (e.g.,
Streptococcus sanguis) must be given upon first mention. The generic name may be abbreviated
thereafter with the first letter of the genus (e.g., S. sanguis). If abbreviation of the generic name
could cause confusion, the full name should be used. If the vernacular form of a genus name (e.g.,
streptococci) is used, the first letter of the vernacular name is not capitalized and the name is not
italicized. Use of two letters of the genus (e.g., Ps. for Peptostreptococcus) is incorrect, even though
it might avoid ambiguity. With regard to drugs, generic names should be used instead of proprietary
names. If a proprietary name is used, it must be attached when the term is first used.
5

d) Trade names
Generic terms are to be used whenever possible, but trade names and manufacturer name, city,
state, and country should be included parenthetically at first mention.
5.2. STRUCTURE
Article material should appear in the following order:
Title Page
Abstract and Keywords
Text
Acknowledgments and Disclosure statements
References
Tables
Figures (should not be embedded in the article)
Figure Legends
Authors should retain a copy of their article for their own records.
5.3. ORIGINAL ARTICLES FORMAT AND STRUCTURE
(see ORIGINAL ARTICLE TEMPLATE)
Article format and structure. Articles should be typed in a 12-point font and double-spaced with a
2.5 mm margin all around. Number all pages.
Title page. Page 1 should include the title of the article (descriptive but as concise as possible) and
the full name(s), of the authors and institutional affiliation(s). Fax, email address, and complete
mailing address must also be provided for the corresponding author.
Abstract/Keywords. Page 2 should include a maximum 250-word structured abstract the following
four headings:
Objectives (no abbreviations);
Material and Methods;
Results;
Conclusions (no abbreviations).
A maximum of six keywords or short phrases, drawn from MeSH documentation, to facilitate
indexing should be listed below the abstract in alphabetical order. Medical subjects heading is
using
MeSH
Browser
available
on:
http://www.nlm.nih.gov/mesh/meshhome.html
http://www.nlm.nih.gov/mesh/MBrowser.html
INTRODUCTION. Summarize the rationale and purpose of the study, giving only pertinent
references. Clearly state the working hypothesis.
MATERIAL AND METHODS. This section lists the methods used in the study in sufficient detail
so that other investigators would be able to reproduce the research. When established methods are
used, the author need only refer to previously published reports; however, the authors should
provide brief descriptions of methods that are not well known or that have been modified. Identify
all drugs and chemicals used, including both generic and, if necessary, proprietary names and doses.
The populations for research involving humans should be clearly dened and enrolment dates
provided.
Clinical trials should be reported using the CONSORT guidelines available at www.consortstatement.org. It should be described four stages of a trial:
1. Enrolment;
2. Intervention allocation;
3. Follow-up;
4. Analysis.
You can use a CONSORT flow diagram. A CONSORT checklist should also be included in the
submission material.
6

JOMR encourages authors submitting articles reporting from a clinical trial to register the trials in
any of the following free, public clinical trials registries:
www.clinicaltrials.gov,
http://clinicaltrials.ifpma.org/no_cache/en/myportal/index.htm,
http://isrctn.org/. The clinical trial registration number and name of the trial register will then be
published with the paper.
Statistical analysis (subsection). Indicate the statistical methods used, if applicable. Include the
short description of Mean (SD) e.g. Parametric data were expressed as mean and standard
deviation (M [SD]). Statistical significance level was defined at P = 0.05.
RESULTS. Present results in a logical sequence in the text, tables, and illustrations. Do not repeat
in the text all the data in the tables or illustrations; emphasize only important observations.
DISCUSSION. Emphasize the new and important aspects of the study and the conclusions that
follow from them. Do not repeat in detail data or other material given in the Introduction or Results
section. Relate observations to other relevant studies and point out the implications of the findings
and their limitations.
CONCLUSIONS. Link the conclusions with the goals of the study but avoid unqualified
statements and conclusions not adequately supported by the data. In particular, authors should avoid
making statements on economic benefits and costs unless their article includes the appropriate
economic data and analyses. Avoid claiming priority and alluding to work that has not been
completed. New hypotheses can be stated when warranted, but should be clearly labelled as such
(no abbreviations).
5.4. LITERATURE REVIEWS FORMAT AND STRUCTURE
Article format and structure. Articles should be typed in a 12-point font and double-spaced with a
2.5 mm margin all around. Number all pages.
Title page. Page 1 should include the title of the article (descriptive but as concise as possible) and
the full name(s), of the authors and institutional affiliation(s). Fax, email address, and complete
mailing address must also be provided for the corresponding author.
Abstract/Keywords should be typed on Page 2.
The abstract should summarize the main conclusions of the review in no more than 250-words and
the following four headings:
Objectives (no abbreviations);
Material and Methods;
Results;
Conclusions (no abbreviations).
A maximum of six keywords or short phrases, drawn from MeSH documentation, to facilitate
indexing should be listed below the abstract in alphabetical order. Medical subjects heading is
available
on:
http://www.nlm.nih.gov/mesh/meshhome.html
using
MeSH
Browser
http://www.nlm.nih.gov/mesh/MBrowser.html
INTRODUCTION. A question or series of related questions to be addressed should be given;
rationales for asking these questions and why the questions are timely should be explained.
MATERIAL AND METHODS. The method of reviewing the literature should be discussed (e.g.,
bibliographic indexes and databases used, limits on years covered by the search, languages
searched, and other important information regarding the search process should be described). For
comprehensive or systematic literature review follow the PRISMA Statement: http://www.prismastatement.org/statement.htm
You can use templates of the PRISMA flow diagram and PRISMA 2009 Checklist. You should
include following information:
Protocol and registration if exists;
Eligibility criteria;
Information sources;
Search;
Study selection;
7

 Data collection process;

Data items;
Risk of bias in individual studies;
Summary measures;
Synthesis of results;
Risk of bias across studies;
Additional analyses.
Look at PRISMA flow diagram and PRISMA 2009 Checklist for more details: http://www.prismastatement.org/statement.htm
RESULTS. A sequence of logical subsections that reflect the area being reviewed should be
developed. This section should be a critical analysis of the literature, including arguments needed to
support the conclusions reached; why certain papers not meeting well described critical standards,
such as randomized clinical trials, were not used as evidence; and what issues remain unresolved
and need further study. Evidence tables are often useful in summarizing reviewed literature, and
various statistical analyses appropriate to reviewing literature, such as meta-analysis, should be
considered.
DISCUSSION. Summarize the main findings including the strength of evidence for each main
outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy
makers).
Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g.,
incomplete retrieval of identified research, reporting bias).
CONCLUSIONS. Link the conclusions with the goals of the study but avoid unqualified
statements and conclusions not adequately supported by the data. In particular, authors should avoid
making statements on economic benefits and costs unless their article includes the appropriate
economic data and analyses. Avoid claiming priority and alluding to work that has not been
completed. New hypotheses can be stated when warranted, but should be clearly labelled as such
(no abbreviations).
5.5. CASE REPORTS FORMAT AND STRUCTURE
Article format and structure. Articles should be typed in a 12-point font and double-spaced with a
2.5 mm margin all around. Number all pages.
Title page. Page 1 should include the title of the article (descriptive but as concise as possible) and
the full name(s), of the authors and institutional affiliation(s). Fax, email address, and complete
mailing address must also be provided for the corresponding author.
Abstract/Keywords should be typed on Page 2.
Case Reports and Case Series should be submitted with a structured abstract, consisting of no more
than 250-words and the following four paragraphs:
Background: Describes the clinical situation being discussed (no abbreviations).
Methods: Describes the clinical procedures (surgical and non-surgical) performed.
Results: Describes the clinical results.
Conclusions: Reports what authors have concluded, specifically clinical implications in
practice situations (no abbreviations).
A maximum of six keywords or short phrases, drawn from MeSH documentation, to facilitate
indexing should be listed below the abstract in alphabetical order. Medical subjects heading is
using
MeSH
Browser
available
on:
http://www.nlm.nih.gov/mesh/meshhome.html
http://www.nlm.nih.gov/mesh/MBrowser.html
INTRODUCTION. This section should include a critical review of the pertinent literature.
CASE DESCRIPTION AND RESULTS. This section describes the case or cases, including all
relevant data. For ease of presentation, tables describing longitudinal data in a chronological form
may be useful. Carefully selected, high-quality clinical photographs in full colour, as well as
radiographs, are encouraged.
8

DISCUSSION. This should include findings, put into perspective with respect to the field and
literature. Unique arguments and new information gained should be summarized. Consideration of
the clinical significance of the case(s) should be emphasized in all sections.
CONCLUSIONS. Link the conclusions with the goals of the study but avoid unqualified
statements and conclusions not adequately supported by the data. In particular, authors should avoid
making statements on economic benefits and costs unless their article includes the appropriate
economic data and analyses. Avoid claiming priority and alluding to work that has not been
completed. New hypotheses can be stated when warranted, but should be clearly labelled as such
(no abbreviations).
5.6. ACKNOWLEDGMENTS AND DISCLOSURE STATEMENTS
a) Acknowledgments
At the end of the Discussion, acknowledgments may be made to individuals who contributed to the
research or the article preparation at a level that did not qualify for authorship. This may include
technical help or participation in a clinical study. Authors are responsible for obtaining written
permission from persons listed by name. Read more in chapter 2.4.
b) Disclosure Statement
Possible conflict(s) of interests should be revealed. Read more in chapter 2.4.
5.7. REFERENCES
All references given must be cited in the text, numbered in order of appearance in square
brackets, e.g. [1]; [2,4,7] or [2-5].
The reference list should be double-spaced at the end of the article in numeric sequence.
Please, delete all footnotes as references in article
Do not include unpublished data or personal communications in the reference list. Cite such
references parenthetically in the text and include a date.
Avoid using abstracts as reference.
We would greatly appreciate if you could append a "[Medline: 12656872]" (where 12656872 is
the PubMed - indexed for MEDLINE) at the end of a reference. This speeds up our
copyediting/typesetting process and prevents citation errors.
You may (in particular for references not listed in PubMed) add the DOI at the end of the
reference (e.g. [doi: 10.1034/j.1600-0501.2003.140202.x]). The DOI is a unique identifier which is
published by most journals somewhere within the article. You may check whether a DOI is correct
using the DOI resolver at http://dx.doi.org/.
Provide complete information for each reference, including names of all authors. Do not use et
al. to abbreviate authors. If the reference is to part of a book, also include the title of the chapter (or
part) and names of the book's editor(s).
Journal reference style should be based on Vancouver system and on "Uniform requirements for
articles
submitted
to
biomedical
journals"
(JAM
1997;
277:927-34,
http://www.nlm.nih.gov/bsd/uniform_requirements.html). Some examples:
1. Standard journal article
Juodzbalys G. Instrument for extraction socket measurement in immediate implant installation. Clin
Oral Implants Res. 2003 Apr;14(2):144-9. [Medline: 12656872] [doi: 10.1034/j.16000501.2003.140202.x]
2. Journal article on the Internet
Juodzbalys G, Wang HL, Sabalys G. Injury of the Inferior Alveolar Nerve during Implant
Placement: a Literature Review. J Oral Maxillofac Res. 2011 Apr 1;2(1):e1. [URL:
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm] [Medline: 24421983] [PMC free
article: 3886063] [doi: 10.5037/jomr.2011.2101]
9

3. Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In:
Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill;
2002. p. 93-113.
4. Conference proceedings
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell
Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
Note: If conference proceedings are available through Medline, please use the Medline citation
rather than the style above - for example in case of AMIA proceedings or IMIA proceedings
(=Medinfo) the citation is as follows:
Mandl KD, Kohane IS. Healthconnect: clinical grade patient-physician communication. Proc AMIA
Symp 1999;(1-2):849-53
Hachem F, Bellet J, Flory A, Leverve X. A generic model for Internet-accessed databases in
epidemiology: a nutritional application. Medinfo 1998;9 Pt 2:1310-3.
5, Article not in English
Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor
Laegeforen. 2002;122(8):785-7. Norwegian.
6. Dissertation.
Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation].
Mount Pleasant (MI): Central Michigan University; 2002.
5.8. HEADINGS AND SUBHEADING
For the Headings and subheadings use the following text decorations:
FIRST HEADING: UPPERCASE, BOLD
First level subheading: Bold
Second level subheading: Bold, italic
Example:
MATERIAL AND METHODS
Guidelines to identify mandibular vital structures
Mandibular canal region
Mental foramen region
Anterior loop of the mental nerve region
In some cases, you may need "third level," even "fourth level," subheadings (the main subheading
being the "first level") then use the following:
Third level subheading: Normal
Fourth subheading: Italic
5.8. TABLES AND FIGURES
All tables and figures should be numbered and cited in the text in order of appearance.
All tables and figures should be grouped at the end of the text in the same Microsoft PC-Word
file.
All figures should be uploaded separately with the article during the submission.
a) Tables
Tables should be numbered consecutively with Arabic numerals (Table 1) in the order of their
appearance in the text. A brief descriptive title should be supplied for each. Explanations, including
abbreviations, should be listed as footnotes, not in the heading. Every column should have a
10

heading. For each row should be created a new table row, rather than writing multiple rows into one
cell. Do not use internal horizontal or vertical rules.
Statistical measures of variations such as standard deviation or standard error of the mean should be
included as appropriate in the footnotes.
b) Figures
All figures should clarify the text and their number should be kept to a minimum. All pictures
should be referenced in the text using parentheses (e.g. Figure 1; Figures 2A and 2B; Figure 3A-C).
Details must be large enough to retain their clarity after reduction in size. Each figure should have a
legend. All illustrations must be the highest quality! Please submit all graphics as separate files or
send via email info@ejomr.org.
Preparation of Electronic Figures for Publication
Illustrative figures should also be uploaded as separate (supplementary) high resolution and quality
files, even if the figures are included in your article file. The file names should contain the number
of the figure (e.g., Figure 1.jpg, Figure 2.tif, Figure 3.png, Figure 4.psd).
5.9. FIGURE LEGENDS
Figure legends should be grouped at the end of the text on a separate sheet. Detailed captions are
encouraged. Legends should be typed double-spaced with Arabic numbers corresponding to the
figure. When arrows, symbols, numbers, or letters are used, explain each clearly in the legend; also
explain internal scale, original magnification, and method of staining as appropriate. Panel labels
should be in capital letters. Legends should not appear on the same page as the actual figures.
5.10. PERMISSIONS AND WAIVERS
a) Permission
Permission of author and publisher must be obtained for the direct use of material (text, photos, and
drawings) under copyright that does not belong to the author.
b) Waivers
Waivers must be obtained for photographs showing persons. When such waivers are not supplied,
faces will be masked to prevent identification.
Permissions and waivers should be emailed along with the Mandatory Submission Form to the
Editorial Assistant.
5.11. STATISTICS
Statistical methods should be described such that a knowledgeable reader with access to the original
data could verify the results. Wherever possible, results should be quantified and appropriate
indicators of measurement error or uncertainty given. Sole reliance on statistical hypothesis testing
or normalization of data should be avoided. Data in as close to the original form as reasonable
should be presented. Details about eligibility criteria for subjects, randomization, and methods for
blinding of observations, treatment complications, and numbers of observations should be included.
Losses to observations, such as dropouts from a clinical trial, should be indicated. General-use
computer programs should be listed. Statistical terms, abbreviations, and symbols should be
dened.

CONTACTS:
Editorial Assistant
Nerijus Sukaitis
12 Vainiku, LT-46383
Kaunas, Lithuania
E-mail: info@ejomr.org

11

12